--- https://www.has-sante.fr/jcms/p_3470178/fr/acces-precoce-des-medicaments-un-bilan-positif-apres-deux-ans-de-mise-en-place-du-dispositif 2023 France technical report devices GNAQ Gene Mutation MGMT Gene Promoter Methylation Positive Lymph Node ATRX Gene Mutation During or After PAS Positive GDC Therapeutic Agent Terminology BAP1 Gene Mutation NRAS Gene Mutation pharmaceutical preparations Status Post ETV Gene Rearrangement Hepatitis C Virus RNA Positive GNA11 Gene Mutation Entrapment of Device SDHA Positive HRAS Gene Mutation ESR2 Positive device, nos ERBB2 Gene Amplification TERT Promoter Mutation PAX8 Gene Rearrangement One to Two Years SDHB Positive ERBB2 Gene Mutation Positive Number Checkup RET/PTC Rearrangement Progesterone Receptor Positive ERG Gene Rearrangement FGFR3 Gene Mutation FGFR2 Gene Mutation Set, Psychology KIT Positive FGFR1 Gene Rearrangement drug, nos Hepatitis B Surface Antibody Positive CDH1 Gene Mutation Balance Sheet equipment and supplies 1p/19q Codeletion Hepatitis B DNA Positive Estrogen Receptor Positive ANO1 Positive c-MET Gene Amplification Positive EBV Test FGFR3 Gene Rearrangement FGFR2 Gene Rearrangement IDH Gene Family Mutation Hepatitis B Virus Surface Antigen Positive PD-L1 Positive Human Immunodeficiency Virus Positive Pharmacologic Substance CTNNB1 Gene Mutation KRAS Gene Mutation
--- https://dumas.ccsd.cnrs.fr/dumas-04414540 2023 France dissertations, academic Health Professional Preselector Device Destination homo sapiens zoonosis, nos health personnel Zoonotic Infection Prescreen Extranodal Involvement Severity of Symptom Score 0 MLH1 Gene Promoter Hypermethylation Regulatory Submission Splayed emigration and immigration Human Perineural Invasion File Submitted france Tumor Necrosis Present Myometrial Invasion One Health french Oprelvekin Lymphatic Invasion is Present Tumor Regression Submitted for Emergency Use Authorization Informed Radial-Femoral Lag Present health humans Tumor Cell Necrosis is Present Presentation Absent No Information Available Informative MGMT Gene Promoter Methylation Tumor Infiltrating Lymphocyte is Present Metropolitan France Ulceration is Present zoonoses
--- https://pgtmsite.files.wordpress.com/2024/01/pertuzumab_position-preliminaire_final.pdf 2014 Canada drug information PAX8 Gene Rearrangement KIT Positive pertuzumab NRAS Gene Mutation SDHB Positive c-MET Gene Amplification KRAS Gene Mutation IDH Gene Family Mutation Hepatitis C Virus RNA Positive PAS Positive FGFR2 Gene Rearrangement Positive Number Estrogen Receptor Positive ANO1 Positive breast cancer GNAQ Gene Mutation FGFR1 Gene Rearrangement pertuzumab Human Immunodeficiency Virus Positive 1p/19q Codeletion HER-2 positive breast cancer ESR2 Positive Hepatitis B Virus Surface Antigen Positive HRAS Gene Mutation Breast Cancer Therapeutic Procedure Herero Language Positive Lymph Node Positive EBV Test RET/PTC Rearrangement FGFR3 Gene Mutation SDHA Positive TERT Promoter Mutation Pertuzumab MGMT Gene Promoter Methylation ERG Gene Rearrangement GNA11 Gene Mutation Metastatic Malignant Neoplasm in the Breast breast neoplasms pertuzumab ATRX Gene Mutation ERBB2 Gene Mutation neoplasm, malignant Hepatitis B DNA Positive Hepatitis B Surface Antibody Positive FGFR3 Gene Rearrangement BAP1 Gene Mutation FGFR2 Gene Mutation PD-L1 Positive ERBB2 Gene Amplification CDH1 Gene Mutation CTNNB1 Gene Mutation ETV Gene Rearrangement Progesterone Receptor Positive